IMS Health is being stolen

in FP: Latest by

RxIt was announced Thursday that IMS Health was to be stolen from its shareholders for $4 billion or about $22 share; a private equity firm will buy them out. IMS Health should have free cash flows this year over $340 million (the actual number should be higher than $400 million, but is benefited by a $60 million onetime tax benefit).

So this company, which has virtually no competition, has barriers to entry impossible for a new entrant to overcome, and a cash printing machine will be sold for about 12 times free cash flows. Over the past year we’ve seen much lower quality companies being sold for much higher valuations than this.  Most recently, Burlington Northern Santa Fe, which has a significant competitive advantage but has far inferior return on capital and free cash flow generation than IMS, is to be purchased by Mr. Buffett for about 20 times earnings and 30 or more times free cash flows. IMS Health’s management and board have a history of making dumb capital allocation decisions, but this one may go down in history as their dumbest.

We own these shares and will probably hold on to them in the hope that shareholders will refuse this offer.

Vitaliy N. Katsenelson, CFA, is a portfolio manager/director of research at Investment Management Associates in Denver, Colo. He is the author of “Active Value Investing: Making Money in Range-Bound Markets” (Wiley 2007). For more information click here.

P.S. Here is a PDF of my recommended book list for 2009.

Tags:

Vitaliy N. Katsenelson, CFA, is Chief Investment Officer at Investment Management Associates in Denver, Colo. He is the author of Active Value Investing (Wiley) and The Little Book of Sideways Markets (Wiley). His books were translated into eight languages. Forbes Magazine called him "The new Benjamin Graham".

Leave a Reply

Latest from FP: Latest

Apple vs Coke

Great Stock = Great Company + Great Valuation (Apple vs Coke) Valuation
Go to Top

DON`T MISS OUT!

Get the latest investment articles in your inbox every week

"Vitaliy Katsenelson is the new Benjamin Graham."

- Forbes

Tired of generic investment advice?

CUT THROUGH THE BS - JOIN 15,000 READERS

"Vitaliy Katsenelson is the new Benjamin Graham."

- Forbes

JOIN TO OUR NEWSLETTER

Tired of generic investment advice?

Sign Up for Articles

Join tens of thousands of readers